Vaccines for preventing rotavirus diarrhoea: vaccines in use-Reference-Cited by-同舟云学术

Vaccines for preventing rotavirus diarrhoea: vaccines in use

Published:2021-11-17 Issue:11 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Bergman Hanna¹,Henschke Nicholas¹,Hungerford Daniel²³,Pitan Femi⁴,Ndwandwe Duduzile⁵,Cunliffe Nigel²³,Soares-Weiser Karla⁶

Affiliation:

1. Cochrane Response; Cochrane; London UK

2. Institute of Infection, Veterinary and Ecological Sciences; University of Liverpool; Liverpool UK

3. NIHR Health Protection Research Unit in Gastrointestinal Infections; University of Liverpool; Liverpool UK

4. Chevron Corporation; Lagos Nigeria

5. Cochrane South Africa; South African Medical Research Council ; Cape Town South Africa

6. Editorial & Methods Department; Cochrane; London UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference426 articles.

1. Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 (Rotarix) oral suspension (liquid formulation) when co-administered with expanded program on immunization (EPI) vaccines in Vietnam and the Philippines in 2006-2007;Anh;Vaccine,2011

2. A phase II, randomized, double-blind, placebo-controlled study to evaluate the immunogenicity, reactogenicity and safety of two doses of GlaxoSmithKline (GSK) Biologicals’ oral live attenuated human rotavirus (HRV) liquid vaccine, when given to healthy infants, in Philippines www.gsk-studyregister.com/study/3204

3. Immunogenicity and safety of two doses of GlaxoSmithKline (GSK) Biologicals' oral live attenuated human rotavirus (HRV) liquid vaccine (GSK 357941A) in healthy infants clinicaltrials.gov/show/NCT00432380

4. Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 (Rotarix) oral suspension (liquid formulation) when co-administered with expanded program on immunization (EPI) vaccines in Vietnam and the Philippines in 2006-2007;Anh;Vaccine,2011

5. Anh DD Thiem VD Hutagalung Y Bock HL Suryakiran P Delem A Immunogenicity, reactogenicity and safety of the oral live attenuated human rotavirus vaccine RIX4414 (Rotarix™) oral suspension (liquid formulation) in Vietnamese Infants 13th International Congress on Infectious Diseases Abstracts, Poster Presentations; June 19-22, 2008; Kuala Lumpur, Malaysia 2008

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in research and development of preventive vaccines for children in China;Frontiers in Pediatrics;2024-07-03

2. Driving forces of continuing evolution of rotaviruses;World Journal of Virology;2024-06-25

3. Navigating Viral Gastroenteritis: Epidemiological Trends, Pathogen Analysis, and Histopathological Findings;Cureus;2024-05-27

4. Combatting infectious diarrhea: innovations in treatment and vaccination strategies;Expert Review of Vaccines;2024-02-19

5. Genotyping and Molecular Characterization of VP6 and NSP4 Genes of Unusual Rotavirus Group A Isolated from Children with Acute Gastroenteritis;Advances in Virology;2024-01